.2 mg compounded semaglutide Injection for Weight Loss Glp 1 Wesley Chapel Sem-P (Semaglutide) Solution for Injection:2 mg/1.5 mL Nausea

.2 mg compounded semaglutide Injection for Weight Loss Glp 1 Wesley Chapel Sem-P (Semaglutide) Solution for Injection:2 mg/1.5 mL Nausea

Glp 1 Wesley Chapel

Each receptor contributes distinct effects: GLP-1 Receptor Component Glucose-dependent insulin secretion from pancreatic beta cells Glucagon suppression in pancreatic alpha cells Slowed gastric emptying Hypothalamic appetite reduction GIP Receptor Component Additional insulin secretion enhancement (synergistic with GLP-1) Direct adipose tissue effects on lipid metabolism Centrally mediated appetite effects via brain GIP receptors Glucagon Receptor Component (Unique to Retatrutide) Increased energy expenditure — glucagon receptor activity raises metabolic rate Hepatic glucose output modulation — increases glucose production in liver (counterbalanced by GLP-1’s insulin effects) Direct fatty acid oxidation effects in liver and muscle tissue Body composition effects from energy expenditure changes The glucagon receptor component is what makes retatrutide unique

Nausea

Sem-P (Semaglutide) Solution for Injection:2 mg/1.5 mL

The sustained activation of GLP-1 receptors improves the peptide’s metabolic efficiency over time